This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Oslo Universitetssykehus Hf. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Odrun Arna Gederaas: Innovator in Photopheresis Technology
Introduction
Odrun Arna Gederaas is a notable inventor based in Trondheim, Norway. She has made significant contributions to the field of medical technology, particularly in the area of extracorporeal photopheresis.
Latest Patents
Gederaas holds a patent for the "Modification of extracorporeal photopheresis technology with porphyrin precursors." This invention relates to the use of a photoactivatable Porphyrin-Derivative in extracorporeal photophoresis (ECP) treatment. In this process, a patient's blood or part of it containing the said Porphyrin-derivative is exposed to light of a wavelength that activates the photoactivatable Porphyrin-Derivative.
Career Highlights
Odrun Arna Gederaas is affiliated with Oslo Universitetssykehus HF, where she continues to advance her research and innovations in medical technology. Her work has the potential to improve treatment outcomes for patients undergoing photopheresis.
Collaborations
Gederaas collaborates with esteemed colleagues, including Qian Peng and Trond Warloe, who contribute to her research endeavors and innovations.
Conclusion
Odrun Arna Gederaas is a pioneering inventor whose work in photopheresis technology exemplifies the intersection of innovation and healthcare. Her contributions are poised to make a lasting impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile